Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi P Shah

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|June 18, 2010
Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studiesRavi P Shah, Saranjit Singh
AAPS Pharmscitech|May 10, 2023
Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark StudySonali Jain, Ravi P Shah
Drug Testing and Analysis|September 30, 2010
Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drugSurbhi Mehta, Ravi P Shah, Saranjit Singh
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2009
Identification and characterization of degradation products of irbesartan using LC-MS/TOF, MS(n), on-line H/D exchange and LC-NMRRavi P Shah, Archana Sahu, Saranjit Singh
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 5, 2026
A way forward for generic development of telmisartan tablets: Integrating critical material attributes and bio-predictive dissolution for target product profileMegha Pillai, Ravi P Shah, Pinaki Sengupta
Rapid Communications in Mass Spectrometry : RCM|February 6, 2008
Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation productsRavi P Shah, Vijay Kumar, Saranjit Singh
Journal of Pharmaceutical and Biomedical Analysis|March 18, 2008
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation productsVijay Kumar, Ravi P Shah, Saranjit Singh
Journal of the American Society for Mass Spectrometry|April 26, 2024
Bioanalysis of Stress Biomarkers through Sensitive HILIC-MS/MS Method: A Stride toward Accurate Quantification of MDA, ACR, and CTAHarsh Thakkar, Shriya Gangakhedkar, Ravi P Shah
Analytical and Bioanalytical Chemistry|February 7, 2013
LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug developmentRavi P Shah, Archana Sahu, Saranjit Singh
Journal of Pharmaceutical Sciences|November 29, 2024
In-situ formation and evaluation of N-nitrosamine drug substance related impurities in glycopeptides implying orbitrap mass spectrometrySree Teja Paritala, Nitish Sharma, Ravi P Shah
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Pharmaceutical and Biomedical Analysis|June 18, 2010
Identification and characterization of a photolytic degradation product of telmisartan using LC-MS/TOF, LC-MSn, LC-NMR and on-line H/D exchange mass studiesRavi P Shah, Saranjit Singh
AAPS Pharmscitech|May 10, 2023
Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark StudySonali Jain, Ravi P Shah
Drug Testing and Analysis|September 30, 2010
Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: application to valsartan, a model drugSurbhi Mehta, Ravi P Shah, Saranjit Singh
Journal of Pharmaceutical and Biomedical Analysis|December 19, 2009
Identification and characterization of degradation products of irbesartan using LC-MS/TOF, MS(n), on-line H/D exchange and LC-NMRRavi P Shah, Archana Sahu, Saranjit Singh
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 5, 2026
A way forward for generic development of telmisartan tablets: Integrating critical material attributes and bio-predictive dissolution for target product profileMegha Pillai, Ravi P Shah, Pinaki Sengupta
Rapid Communications in Mass Spectrometry : RCM|February 6, 2008
Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation productsRavi P Shah, Vijay Kumar, Saranjit Singh
Journal of Pharmaceutical and Biomedical Analysis|March 18, 2008
LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation productsVijay Kumar, Ravi P Shah, Saranjit Singh
Journal of the American Society for Mass Spectrometry|April 26, 2024
Bioanalysis of Stress Biomarkers through Sensitive HILIC-MS/MS Method: A Stride toward Accurate Quantification of MDA, ACR, and CTAHarsh Thakkar, Shriya Gangakhedkar, Ravi P Shah
Analytical and Bioanalytical Chemistry|February 7, 2013
LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug developmentRavi P Shah, Archana Sahu, Saranjit Singh
Journal of Pharmaceutical Sciences|November 29, 2024
In-situ formation and evaluation of N-nitrosamine drug substance related impurities in glycopeptides implying orbitrap mass spectrometrySree Teja Paritala, Nitish Sharma, Ravi P Shah
Pageof 5